We should embrace innovation and technology that is available to maximize quality patient care, one Mount Sinai doctor said.

Dr. Chris Hillman, Global AI Lead at Teradata, joins eSpeaks to explore why open data ecosystems are becoming essential for enterprise AI success. In this episode, he breaks down how openness — in ...

PARIS, November 18, 2024--(BUSINESS WIRE)--BrightHeart, a leading AI innovator in obstetric and pediatric cardiology technology, announces it has received FDA 510(k) clearance for its first artificial ...

Fetal heart monitoring is a common practice used by healthcare providers to examine a baby’s heart rate during the latter ...

Doctors in the Raquel and Jaime Gilinski Department of Obstetrics, Gynecology and Reproductive Science at Mount Sinai have ...

Mount Sinai pilots detect fetal heart issues using FDA-approved AI, improving congenital defect detection and reducing ultrasound reading time.

Please provide your email address to receive an email when new articles are posted on . An AI software system improved ultrasound detection of fetal congenital heart defects compared with unaided ...

PARIS, May 14, 2025--(BUSINESS WIRE)--BrightHeart, a global leader in artificial intelligence (AI) solutions for obstetrics and pediatric cardiology, announced today it has received 510(k) clearance ...

Medical devicemaker BrightHeart has earned FDA clearance for its artificial intelligence software designed to transform prenatal ultrasound evaluations of the fetal heart. Congenital heart defects ...

Identifying issues early allows parents and doctors to prepare for medical care after birth. And in some cases, doctors can intervene before the baby is born. Thanks to advances in imaging, surgical ...